MANAGEMENT THALASSEMIA MAJOR WITH TRIPHALADIAVALEHA

A CLINICAL STUDY ON BEEJADUSHTIJANYA PANDU-THALASSEMIA MAJOR AND ITS MANAGEMENT WITH TRIPHALADIAVALEHA

Status

Recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2012/08/002885

Enrollment

Registered

2012-08-13

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Thalassemia major

Interventions

Intervention1: Triphaladi avaleha: ï?¶ 6 months-5 years of age group: 2-14 gm in three divided doses ï?¶ 6-10. years of age group : 16-22 gm in three divided doses. ï?¶ 11-12 years of age gr

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed thalassemia major patients. Age groups: 6months - 12 years.

Exclusion criteria

Exclusion criteria: • Complicated cases (having HIV, HBV, infection, hepatic failure. TB etc.) Patient having BT interval for less than 15 days Patient undergone splenectomy Age Children below 6 months and above 12 years

Design outcomes

Primary

Measure	Time frame
prolong in duration of BTtransfusionTimepoint: 8 weeks	—

Secondary

Measure	Time frame
improvement in signs and symptomsTimepoint: 8 weeks	—

Countries

India

Contacts

Public Contactdr Virendra Kori

drvkkori@yahoo.co.in9374548475

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026